ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,29
0,48%
Dow Jones
39 671,04
0,00%
DAX
18 756,66
0,40%
Brent Oil
82,425
1,10%
Bitcoin
69 734,31
0,91%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Synthetic Biologics Inc (SYN)

  7. Synthetic Biologics Inc (SYN) Actualités

SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:SYN
DateHeureSourceTitreSymboleSociété
27/06/202323h11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
08/06/202313h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
11/05/202314h17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
30/03/202314h18Edgar (US Regulatory)Annual Report (10-k)AMEX:SYNSynthetic Biologics Inc
09/12/202212h04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:SYNSynthetic Biologics Inc
05/12/202222h01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:SYNSynthetic Biologics Inc
29/09/202213h25TipRanksMaxim Group Sticks to Its Buy Rating for Synthetic Biologics (SYN)AMEX:SYNSynthetic Biologics Inc
16/09/202222h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
06/09/202222h31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:SYNSynthetic Biologics Inc
16/08/202223h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:SYNSynthetic Biologics Inc
11/08/202215h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:SYNSynthetic Biologics Inc
04/08/202212h03Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:SYNSynthetic Biologics Inc
17/05/202217h45TipRanksMaxim Group Thinks Synthetic Biologics’ Stock is Going to RecoverAMEX:SYNSynthetic Biologics Inc
23/02/202222h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:SYNSynthetic Biologics Inc
09/02/202213h15PR Newswire (US)Synthetic Biologics to Present at 2022 BIO CEO & Investor ConferenceAMEX:SYNSynthetic Biologics Inc
08/02/202213h15PR Newswire (US)Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDAAMEX:SYNSynthetic Biologics Inc
26/01/202222h05PR Newswire (US)Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022AMEX:SYNSynthetic Biologics Inc
14/12/202113h00PR Newswire (US)Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid TumorsAMEX:SYNSynthetic Biologics Inc
03/11/202121h10PR Newswire (US)Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ETAMEX:SYNSynthetic Biologics Inc
26/10/202113h00PR Newswire (US)Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021AMEX:SYNSynthetic Biologics Inc
22/10/202123h01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:SYNSynthetic Biologics Inc
21/10/202113h00PR Newswire (US)Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline PhosphataseAMEX:SYNSynthetic Biologics Inc
06/10/202122h36PR Newswire (US)Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of QuorumAMEX:SYNSynthetic Biologics Inc
21/09/202122h30PR Newswire (US)Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of QuorumAMEX:SYNSynthetic Biologics Inc
25/08/202122h31Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)AMEX:SYNSynthetic Biologics Inc
05/08/202122h10PR Newswire (US)Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ETAMEX:SYNSynthetic Biologics Inc
03/08/202123h23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:SYNSynthetic Biologics Inc
03/08/202113h00PR Newswire (US)Synthetic Biologics Expands Option for an Exclusive License Agreement with Massachusetts General HospitalAMEX:SYNSynthetic Biologics Inc
28/07/202113h00PR Newswire (US)Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021AMEX:SYNSynthetic Biologics Inc
29/06/202113h00PR Newswire (US)Synthetic Biologics Provides Update on SYN-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical TrialAMEX:SYNSynthetic Biologics Inc
 Showing the most relevant articles for your search:AMEX:SYN

Dernières Valeurs Consultées

BIT
I07031
INTESA SANPAOLO
COIN
GPTEUR
USOTC
JPEIF
JP Morgan ETFs Ireland I... (CE)
COIN
DBETBTC
Decent.bet
USOTC
BLHI
Blue (CE)
LSE
39WC
Res.mtg 17 B1as
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés